Allergan Adds Accomplished Financial Executive to Its Board of Directors.

Business Editors

IRVINE, Calif.--(BUSINESS WIRE)--Feb. 28, 2003

Allergan, Inc. (NYSE:AGN) today announced that Russell T. Ray was appointed to the Company's Board of Directors effective April 1, 2003.

Mr. Ray is a Managing Director of Chesapeake Strategic Advisors, a firm specializing in providing advisory services to health care and life sciences companies. Prior to founding Chesapeake, Mr. Ray was the Global Co-Head of the Credit Suisse First Boston Health Care Investment Banking Group, where he focused on providing strategic and financial advice to life sciences, health care services and medical device companies. During his investment banking career, Mr. Ray successfully completed over 175 transactions for leading health care companies worldwide.

"The appointment of Russell Ray brings to Allergan's Board of Directors a leading expert respected for his extensive knowledge, experience and success in the banking and finance industry," said David E.I. Pyott, Chairman, President and Chief Executive Officer of Allergan. "Russ' strengths help to diversify and accentuate an already strong Board whose vision and experience continue to foster growth and create stockholder value."

Prior to joining Credit Suisse First Boston, Mr. Ray spent twelve years at Deutsche Bank and its predecessor entities; BT Alex. Brown and Alex. Brown; as Global Head of Health Care Investment Banking. He began his career in investment banking at Merrill Lynch in 1982 as a member of the firm's High Tech and Emerging Growth Group.

Mr. Ray received his B.S. in Engineering from the U.S. Military Academy, a B.A. in Zoology and Ecology from the University of Washington, an M.S. in Biology from the University of Pennsylvania and an M.B.A. in Finance from the Wharton School.

Forward-Looking Statements

Statements regarding future plans, forecasts, and events are "forward-looking statements." These statements are based on current expectations and intentions only. If underlying assumptions prove inaccurate, or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations. Information concerning risk factors can be found in press releases issued by Allergan as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Certain Factors and Trends Affecting Allergan and its Businesses" in Allergan's 2001 Form 10-K and its Form 10-Q for the quarter ended September 27, 2002. Copies of Allergan's press releases and additional information about Allergan are available on the World Wide Web at www.allergan.com, or you can contact the Allergan Investor Relations Department by calling 714/246-4636.

About Allergan, Inc.

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives.